A detailed history of Stonnington Group, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Stonnington Group, LLC holds 11,850 shares of FLGT stock, worth $217,329. This represents 0.1% of its overall portfolio holdings.

Number of Shares
11,850
Previous 11,850 -0.0%
Holding current value
$217,329
Previous $352,000 4.83%
% of portfolio
0.1%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 12, 2022

SELL
$49.85 - $96.11 $3.65 Million - $7.04 Million
-73,200 Reduced 86.07%
11,850 $680,000
Q4 2021

Jan 12, 2022

SELL
$77.3 - $105.0 $15,460 - $21,000
-200 Reduced 1.62%
12,150 $1.01 Million
Q4 2021

Jan 12, 2022

BUY
$77.3 - $105.0 $5.64 Million - $7.65 Million
72,900 Added 600.0%
85,050 $7.07 Million
Q3 2021

Oct 12, 2021

BUY
$74.87 - $110.87 $14,974 - $22,174
200 Added 1.65%
12,350 $1.02 Million
Q1 2021

May 21, 2021

BUY
$59.3 - $183.85 $720,495 - $2.23 Million
12,150 New
12,150 $812,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $555M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Stonnington Group, LLC Portfolio

Follow Stonnington Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonnington Group, LLC with notifications on news.